手术与持续药物治疗对药物难治性慢性鼻窦炎的系统评价与Meta分析
该系统评价与Meta分析纳入6项中高质量前瞻性研究(其中5项进入Meta分析),比较药物难治性慢性鼻窦炎患者在接受适当药物治疗后继续药物治疗与接受内镜鼻窦手术的疗效。Meta分析显示,与持续药物治疗相比,内镜鼻窦手术显著改善患者报告的生活质量评分(p<0.00001)和鼻内镜评分(p<0.00001);非汇总分析显示嗅觉、健康效用评分和成本效益改善。
要点
- 内镜鼻窦手术较持续药物治疗显著改善药物难治性慢性鼻窦炎患者的生活质量评分(p<0.00001)。
- 内镜鼻窦手术较持续药物治疗显著改善鼻内镜评分(p<0.00001)。
- 基线生活质量较差者手术后显著改善,基线生活质量较轻者持续药物治疗似可维持结局。
核心结论
- 对于药物难治性慢性鼻窦炎患者,Meta分析显示内镜鼻窦手术较持续药物治疗显著改善客观鼻内镜评分结局。
- 基线生活质量显著下降的药物难治性慢性鼻窦炎患者,内镜鼻窦手术带来显著改善。
- 持续药物治疗似可维持基线生活质量较轻患者的结局。
- 非汇总分析显示,在药物难治性慢性鼻窦炎中,内镜鼻窦手术较持续药物治疗改善健康效用、嗅觉和成本效益。
研究设计与样本
- 系统评价与Meta分析,纳入接受适当药物治疗后接受药物或手术治疗的成人慢性鼻窦炎患者的中高质量前瞻性研究。
- 共识别970篇文献,最终6项研究纳入系统评价,其中5项纳入Meta分析。
主要发现
- 与持续药物治疗相比,内镜鼻窦手术显著改善患者报告的生活质量评分(p<0.00001)。
- 与持续药物治疗相比,内镜鼻窦手术显著改善鼻内镜评分(p<0.00001)。
- 误工天数的差异很大程度上取决于患者对干预措施的选择。
- 非汇总分析显示嗅觉、健康效用评分和成本效益改善。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The currently accepted treatment paradigm of treating chronic rhinosinusitis (CRS) first with appropriate medical therapy (AMT) and then with surgery if patients are refractory to AMT, has been criticized for lack of evidence. The objective of this study was to reassess the literature and establish the highest level of evidence possible regarding further management of CRS patients refractory to AMT. METHODS: This study was a systematic review (SR) with meta-analysis (MA). Adult CRS patients who received AMT and then underwent either medical or surgical therapy in moderate to high level prospective studies were included. Outcomes assessed were disease-specific quality of life (QOL), nasal endoscopy, health-state utility, missed work days, change in cardinal symptoms of CRS, economic impact, and adverse events. RESULTS: A total of 970 manuscripts were identified; 6 studies were ultimately included in the SR with 5 included in the MA. Compared to continued medical therapy, endoscopic sinus surgery (ESS) significantly improved patient-based QOL scores (p < 0.00001) and nasal endoscopy scores (p < 0.00001). Difference in missed work days depended heavily on patient choice of intervention. Unpooled analysis showed improvements in olfaction, health utility scores, and cost-effectiveness. CONCLUSION: On meta-analysis, for CRS patients refractory to AMT, ESS significantly improves objective endoscopic scoring outcomes vs continued medical therapy alone. In patients with refractory CRS who have significant reductions in baseline QOL, ESS results in significant improvements. Continued medical therapy appears to maintain outcomes in patients with less severe baseline QOL. Unpooled analysis demonstrates improvement in health utility, olfaction, and cost-effectiveness following ESS compared to continued medical therapy alone, in medically refractory CRS.
引用
- Patel ZM, Thamboo A, Rudmik L, et al. Surgical therapy vs continued medical therapy for medically refractory chronic rhinosinusitis: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2016. PMID: 27863163. doi:10.1002/alr.21872
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。